Skip to main content
Nadia Khan, MD, Oncology, Chicago, IL

Nadia Khan MD


Instructor of Pediatrics, University of Chicago Medicine

Join to View Full Profile
  • 1520 W Harrison StChicago, IL 60607

  • Phone+1 800-226-2371

  • Fax+1 206-568-7043

Dr. Khan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • MedStar Health Georgetown University
    MedStar Health Georgetown UniversityFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Temple University Hospital
    Temple University HospitalResidency, Internal Medicine, 2008 - 2010
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterInternship, Internal Medicine, 2003 - 2004
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 2003

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2024 - 2026
  • NJ State Medical License
    NJ State Medical License 2024 - 2025
  • CT State Medical License
    CT State Medical License 2024 - 2024
  • WA State Medical License
    WA State Medical License 2022 - 2024
  • PA State Medical License
    PA State Medical License 2008 - 2022
  • DC State Medical License
    DC State Medical License 2011 - 2014
  • MD State Medical License
    MD State Medical License 2013 - 2014
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
    Nadia Khan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Pembrolizumab and Copanlisib for the Treatment of Relapsed or Refractory Mature T-Cell Lymphomas
    Nadia Khan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
    Nadia Khan, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/8/2019

Press Mentions

  • 'Possibility of Cure' for Some Patients with CLL
    'Possibility of Cure' for Some Patients with CLLSeptember 10th, 2019
  • Will Obinutuzumab Replace Rituximab for CLL Combination Treatment?
    Will Obinutuzumab Replace Rituximab for CLL Combination Treatment?September 26th, 2017

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: